文献速递脑血管病

静脉溶栓与急性缺血性卒中患者过敏反应风险的关联

Association Between Intravenous Thrombolysis and Anaphylaxis Among Medicare Beneficiaries With Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2019-09-13

调整人口学、合并症、造影剂、机械取栓及过敏史后,静脉溶栓与过敏反应显著相关(OR 7.8,95%CI 4.3-13.9),过敏反应虽罕见但风险显著升高。

要点

  • 静脉溶栓患者过敏反应发生率为0.54%,未溶栓者为0.07%。
  • 调整混杂因素后,静脉溶栓与过敏反应显著相关(OR 7.8)。
  • 过敏反应虽罕见,但溶栓患者风险显著高于未溶栓患者。

核心结论

  • 急性缺血性卒中患者接受静脉溶栓后过敏反应风险显著高于未接受溶栓者,但绝对发生率较低。

研究设计与样本

  • 回顾性队列研究,使用2008至2015年全美代表性5%的Medicare受益人住院和门诊索赔数据。

主要发现

  • 静脉溶栓组过敏反应发生17例(0.54%;95%CI 0.31%-0.86%),非溶栓组45例(0.07%;95%CI 0.05%-0.09%)。
  • 调整人口学、血管危险因素、Charlson合并症指数、静脉造影剂暴露、机械取栓及过敏史后,静脉溶栓与过敏反应显著相关(OR 7.8;95%CI 4.3-13.9)。
  • 过敏性休克也显示类似关联。

临床怎么用

  • 对接受静脉溶栓的急性缺血性卒中患者,应警惕罕见但可能发生的过敏反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Allergic reactions, including anaphylaxis, can sometimes occur after intravenous thrombolysis in patients with acute ischemic stroke. However, it remains unclear whether patients with stroke who receive thrombolytic agents face a higher risk of anaphylaxis than those who do not receive thrombolytics. Methods- We performed a retrospective cohort study using inpatient and outpatient claims between 2008 and 2015 from a nationally representative 5% sample of Medicare beneficiaries. We included patients who were ≥65 years old and hospitalized with acute ischemic stroke, defined by validated International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. Our exposure was treated with an intravenous thrombolytic agent during the index hospitalization (International Classification of Diseases, Ninth Revision, Clinical Modification code 99.10). Our primary outcome was anaphylaxis, defined using an accepted International Classification of Diseases, Ninth Revision, Clinical Modification code algorithm (989.5, 995.0-4, 995.6x, E905, E905.3, E905.5, or E905.8-9). A secondary outcome was anaphylactic shock (995.0 or 995.6x). Multiple logistic regression was used to evaluate the association between intravenous thrombolysis and anaphylaxis after adjustment for demographics, vascular risk factors, the Charlson comorbidity index, exposure to intravenous contrast dye, treatment with mechanical thrombectomy, and history of allergic reactions. Results- Among 66 989 patients with stroke, the 3176 (4.7%) who underwent intravenous thrombolysis more often had atrial fibrillation (47.7% versus 37.4%) and more often received intravenous contrast dye (44.3% versus 21.9%) but were otherwise similar in terms of demographics and comorbidities. Anaphylaxis developed in 17 (0.54%; 95% CI, 0.31%-0.86%) patients who received intravenous thrombolysis versus 45 (0.07%; 95% CI, 0.05%-0.09%) who did not. After adjustment for demographics, comorbidities, contrast dye, mechanical thrombectomy, and history of allergies, there was a significant association between receipt of intravenous thrombolysis and anaphylaxis (odds ratio, 7.8; 95% CI, 4.3-13.9). We found a similar association for anaphylactic shock. Conclusions- Although a rare occurrence, the risk of anaphylaxis among patients with acute ischemic stroke was significantly higher among those who received intravenous thrombolysis.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Lerario MP, Grotta JC, Merkler AE, et al. Association Between Intravenous Thrombolysis and Anaphylaxis Among Medicare Beneficiaries With Acute Ischemic Stroke. Stroke. 2019. PMID: 31514696. doi:10.1161/STROKEAHA.119.026861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。